{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:20:24Z","timestamp":1765808424606,"version":"3.37.3"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":269,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.prdoa.2024.100272","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T16:12:30Z","timestamp":1728144750000},"page":"100272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Zinc gluconate for Wilson disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Mark S.","family":"LeDoux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prdoa.2024.100272_b0005","first-page":"849","article-title":"Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis","volume":"123","author":"Brewer","year":"1994","journal-title":"J. Lab. Clin. Med."},{"issue":"5","key":"10.1016\/j.prdoa.2024.100272_b0010","first-page":"538","article-title":"Recognition and treatment of neurologic Wilson's disease","volume":"32","author":"Lorincz","year":"2012","journal-title":"Semin. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2024.100272_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clinre.2017.05.011","article-title":"Characteristics and prevalence of Wilson's disease: a 2013 observational population-based study in France","volume":"42","author":"Poujois","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"4","key":"10.1016\/j.prdoa.2024.100272_b0020","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/hep.32805","article-title":"A multidisciplinary approach to the diagnosis and management of Wilson disease: executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases","volume":"77","author":"Schilsky","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prdoa.2024.100272_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1572-0241.1999.00301.x","article-title":"Zinc therapy induction of intestinal metallothionein in Wilson's disease","volume":"94","author":"Brewer","year":"1999","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.prdoa.2024.100272_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/nu15122813","article-title":"Comparison of the potential relative bioaccessibility of zinc supplements-in vitro studies","volume":"15","author":"Osko","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prdoa.2024.100272_b0035","doi-asserted-by":"crossref","first-page":"14714","DOI":"10.1038\/s41598-022-18872-8","article-title":"Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study","volume":"12","author":"Munk","year":"2022","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.prdoa.2024.100272_b0040","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep4.1384","article-title":"Zinc Maintenance therapy for wilson disease: a comparison between zinc acetate and alternative zinc preparations","volume":"3","author":"Camarata","year":"2019","journal-title":"Hepatol. Commun."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112524000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112524000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T11:01:47Z","timestamp":1734606107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112524000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":8,"alternative-id":["S2590112524000434"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2024.100272","relation":{},"ISSN":["2590-1125"],"issn-type":[{"type":"print","value":"2590-1125"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zinc gluconate for Wilson disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2024.100272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100272"}}